Arbutus Biopharma Corp (ABUS)

CIK 1447028 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Arbutus Biopharma Corp.

Recent SEC filings

FiledFormAccession number
Sep 4, 2026SCHEDULE 13G0000921895-26-002494
Aug 24, 2026SC TO-I0001104659-26-100002
Aug 21, 2026SC TO-C0001104659-26-099391
Aug 21, 20268-K0001104659-26-099390
Aug 12, 202610-Q0001447028-26-000045
Aug 12, 2026SCHEDULE 13G/A0000895421-26-000222
Aug 12, 20268-K0001171843-26-005442
Jul 16, 20268-K0001171843-26-004708
Jun 10, 202640001447028-26-000040
Jun 10, 202640001447028-26-000039
Jun 5, 2026S-80001447028-26-000027
May 27, 20268-K0001447028-26-000024
May 15, 2026SCHEDULE 13G/A0001011438-26-000347
May 13, 20268-K0001171843-26-003346
May 13, 202610-Q0001447028-26-000021
Apr 28, 2026SCHEDULE 13D/A0000921895-26-001101
Apr 15, 20268-K0001171843-26-002458
Apr 14, 2026DEF 14A0001140361-26-014623
Apr 14, 2026DEFA14A0001140361-26-014624
Apr 13, 2026SCHEDULE 13D/A0000921895-26-000973
Mar 23, 20268-K0001171843-26-001838
Mar 23, 202610-K0001447028-26-000017
Mar 3, 20268-K0001171843-26-001299
Feb 20, 20268-K0001171843-26-000979
Feb 17, 2026SCHEDULE 13G/A0001011438-26-000149